DELTA PETROLEUM CORPORATION $100,000,000 3.75% Convertible Senior Notes due 2037 Underwriting Agreement
Exhibit
1.1
DELTA PETROLEUM CORPORATION
$100,000,000 3.75% Convertible Senior Notes due 2037
April 19, 2007
X.X. Xxxxxx Securities Inc.
Xxxxxx Brothers Inc.
Deutsche Bank Securities Inc.
As Representatives of the several
Underwriters listed in Schedule 1 hereto
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Xxxxxx Brothers Inc.
Deutsche Bank Securities Inc.
As Representatives of the several
Underwriters listed in Schedule 1 hereto
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
Delta Petroleum Corporation, a Delaware corporation (the “Company”), proposes to issue and
sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are
acting as representatives (the “Representatives”), $100,000,000 principal amount of its 3.75%
Convertible Senior Notes due 2037 (the “Firm Securities”) and, at the option of the Underwriters,
up to an additional $15,000,000 principal amount of its 3.75% Convertible Senior Notes due 2037
(the “Additional Securities” and, together with the Firm Securities, the “Securities”). The
Securities will be issued pursuant to an Indenture (the “Indenture”), to be dated as of the Closing
Date (as defined in Section 2(c)), among the Company, the subsidiaries listed in Schedule 2 hereto
(the “Guarantors”) and U.S. Bank National Association, as trustee (the “Trustee”), and will be
guaranteed on an unsecured senior basis by each of the Guarantors (the “Guarantees”).
The Securities will be convertible into fully paid, nonassessable shares of common stock of
the Company, par value $0.01 per share (the “Common Stock”), on the terms, and subject to the
conditions, set forth in the Indenture. As used herein, “Conversion Shares” means the shares of
Common Stock issuable upon conversion of the Securities.
The Company and the Guarantors hereby confirm their agreement with the several Underwriters
concerning the purchase and sale of the Securities, as follows:
1. Registration Statement. The Company and the Guarantors have prepared and filed
with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as
amended, and the rules and regulations of the Commission thereunder (collectively, the “Securities
Act”), a registration statement on Form S-3 (File No. 333-142180) including a prospectus, relating
to the Securities. Such registration statement, as amended at the time it becomes effective,
including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities
Act to be part of the registration statement at the time of its effectiveness (“Rule 430
Information”), is referred to herein as the “Registration Statement”; and as used herein, the term
“Preliminary Prospectus” means each prospectus included in such
2
registration statement (and any amendments thereto) before it becomes effective, any
prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act and the
prospectus included in the Registration Statement at the time of its effectiveness that omits Rule
430 Information, and the term “Prospectus” means the prospectus in the form first used (or made
available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection
with confirmation of sales of the Securities. If the Company and the Guarantors have filed an
abbreviated registration statement pursuant to Rule 462(b) under the Securities Act (the “Rule 462
Registration Statement”), then any reference herein to the term “Registration Statement” shall be
deemed to include such Rule 462 Registration Statement. Any reference in this Agreement to the
Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to
and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under
the Securities Act, as of the effective date of the Registration Statement or the date of such
Preliminary Prospectus or the Prospectus, as the case may be, and any reference to “amend”,
“amendment” or “supplement” with respect to the Registration Statement, any Preliminary Prospectus
or the Prospectus shall be deemed to refer to and include any documents filed after such date under
the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission
thereunder (collectively, the “Exchange Act”) that are deemed to be incorporated by reference
therein. Capitalized terms used but not defined herein shall have the meanings given to such terms
in the Registration Statement and the Prospectus.
At or prior to the time when sales of the Securities were first made (the “Time of Sale”), the
Company had prepared the following information (collectively, the “Time of Sale Information”): a
prospectus dated April 17, 2007, as supplemented by a preliminary prospectus supplement dated April
17, 2007 relating to the Securities, and each “free-writing prospectus” (as defined pursuant to
Rule 405 under the Securities Act) listed on Annex B hereto.
2. Purchase of the Securities by the Underwriters. (a) The Company agrees to issue
and sell the Firm Securities to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Company the respective principal amount of Firm Securities set forth opposite such Underwriter’s
name in Schedule 1 hereto at a price equal to 97.00% of the principal amount thereof plus accrued
interest, if any, from April 25, 2007 to the Closing Date (as defined below) (the “Purchase
Price”).
In addition, the Company agrees to issue and sell the Additional Securities to the several
Underwriters as provided in this Agreement, and the Underwriters, on the basis of the
representations, warranties and agreements set forth herein and subject to the conditions set forth
herein, shall have the option to purchase, severally and not jointly, from the Company the
Additional Securities at the Purchase Price.
If any Additional Securities are to be purchased, the principal amount of Additional
Securities to be purchased by each Underwriter shall be the principal amount of Additional
Securities which bears the same ratio to the principal amount of Additional Securities being
purchased as the principal amount of Firm Securities set forth opposite the name of such
Underwriter in Schedule 1 hereto (or such number increased as set forth in Section 10 hereof)
3
bears to the principal amount of Firm Securities being purchased from the Company by the
several Underwriters, subject, however, to such adjustments to eliminate any fractional Securities
as the Representatives in their sole discretion shall make.
The Underwriters may exercise the option to purchase the Additional Securities at any time in
whole, or from time to time in part, on or before the thirtieth day following the date of this
Agreement, by written notice from the Representatives to the Company. Such notice shall set forth
the aggregate principal amount of Additional Securities as to which the option is being exercised
and the date and time when the Additional Securities are to be delivered and paid for which may be
the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than
the Closing Date nor later than the tenth full business day (as hereinafter defined) after the date
of such notice (unless such time and date are postponed in accordance with the provisions of
Section 10 hereof). Any such notice shall be given at least two business days prior to the date
and time of delivery specified therein.
(b) The Company and the Guarantors understand that the Underwriters intend to make a public
offering of the Securities as soon after the effectiveness of this Agreement as in the judgment of
the Representatives is advisable, and initially to offer the Securities on the terms set forth in
the Prospectus. The Company and the Guarantors acknowledge and agree that the Underwriters may
offer and sell Securities to or through any affiliate of an Underwriter and that any such affiliate
may offer and sell Securities purchased by it to or through any Underwriter.
(c) Payment for and delivery of the Firm Securities and the Guarantees shall be made at the
offices of Xxxxxxx Xxxxxxx & Xxxxxxxx LLP at 10:00 A.M. New York City time on April 25, 2007, or at
such other time or place on the same or such other date, not later than the fifth business day
thereafter, as the Representatives and the Company may agree upon in writing or, in the case of the
Additional Securities, on the date and at the time and place specified by the Representatives in
the written notice of the Underwriters’ election to purchase such Additional Securities. The time
and date of such payment for the Firm Securities is referred to herein as the “Closing Date” and
the time and date for such payment for the Additional Securities, if other than the Closing Date,
is herein referred to as the “Additional Closing Date.”
Payment for the Securities shall be made by wire transfer in immediately available funds to
the account specified by the Company to the Representatives against delivery to the nominee of The
Depository Trust Company (“DTC”), for the account of the Underwriters, of one or more global notes
representing the Firm Securities (collectively, the “Global Notes”), with any transfer taxes
payable in connection with the sale of the Firm Securities duly paid by the Company. Payment for
any Additional Securities shall be made on the Closing Date or the Additional Closing Date, as
applicable, by wire transfer in immediately available funds to the account specified by the Company
to the Representatives against delivery to the nominee of DTC, for the account of the Underwriters,
of one or more Global Notes representing the Additional Securities, with any transfer taxes payable
in connection with the sale of the Additional Securities duly paid by the Company. The Global
Notes will be made available for inspection by the Representatives not later than 1:00 P.M., New
York City time, on the business day prior to the Closing Date or the Additional Closing Date, as
the case may be.
4
(d) The Company and the Guarantors acknowledge and agree that the Underwriters are acting
solely in the capacity of an arm’s length contractual counterparty to the Company and the
Guarantors with respect to the offering of Securities, Guarantees and Conversion Shares
contemplated hereby (including in connection with determining the terms of the offering) and not as
financial advisors or fiduciaries to, or agents of, the Company, any Guarantor or any other person.
Additionally, neither the Representatives nor any other Underwriter is advising the Company, any
Guarantor or any other person as to any legal, tax, investment, accounting or regulatory matters
in any jurisdiction. The Company and the Guarantors shall consult with their own advisors
concerning such matters and shall be responsible for making their own independent investigation and
appraisal of the transactions contemplated hereby, and neither the Representatives nor any other
Underwriter shall have any responsibility or liability to the Company or any Guarantor with respect
thereto. Any review by the Representatives or any other Underwriter of the Company, the Guarantors
and the transactions contemplated hereby or other matters relating to such transactions will be
performed solely for the benefit of the Underwriters and shall not be on behalf of the Company, the
Guarantors or any other person.
3. Representations and Warranties of the Company and the Guarantors. The Company and
each of the Guarantors jointly and severally represent and warrant to each Underwriter that:
(a) Preliminary Prospectus. No order preventing or suspending the use of any Preliminary
Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of
filing thereof, complied in all material respects with the Securities Act and did not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; provided that the Company and the Guarantors make no
representation and warranty with respect to any statements or omissions made in reliance upon and
in conformity with information relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representatives expressly for use in any Preliminary Prospectus.
(b) Time of Sale Information. The Time of Sale Information, at the Time of Sale did not, and
at the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain
any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided that the Company and the Guarantors
make no representation and warranty with respect to any statements or omissions made in reliance
upon and in conformity with information relating to any Underwriter furnished to the Company in
writing by such Underwriter through the Representatives expressly for use in such Time of Sale
Information. No statement of material fact included in the Prospectus has been omitted from the
Time of Sale Information and no statement of material fact included in the Time of Sale Information
that is required to be included in the Prospectus has been omitted therefrom.
(c) Issuer Free Writing Prospectus. Other than the Preliminary Prospectus and the Prospectus,
neither the Company nor any Guarantor (including their respective agents
5
and representatives, other than the Underwriters in their capacity as such) has not made,
used, prepared, authorized, approved or referred to and will not prepare, make, use, authorize,
approve or refer to any “written communication” (as defined in Rule 405 under the Securities Act)
that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such
communication by the Company or any Guarantor or their respective agents and representatives (other
than a communication referred to in clause (i) below) an “Issuer Free Writing Prospectus”) other
than (i) any document not constituting a prospectus pursuant to clause (a) of Section 2(a)(10) of
the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex B
hereto and other written communications approved in writing in advance by the Representatives.
Each such Issuer Free Writing Prospectus complied in all material respects with the Securities Act,
has been filed in accordance with the Securities Act (to the extent required thereby) and, when
taken together with the Time of Sale Information filed prior to the first use of such Issuer Free
Writing Prospectus, did not, and at the Closing Date and as of the Additional Closing Date, as the
case may be, will not, contain any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading; provided that the Company and the Guarantors make no
representation and warranty with respect to any statements or omissions made in each such Issuer
Free Writing Prospectus in reliance upon and in conformity with information relating to any
Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in any Issuer Free Writing Prospectus.
(d) Registration Statement and Prospectus. The Registration Statement is an “automatic shelf
registration statement” as defined under Rule 405 of the Securities Act that has been filed with
the Commission not earlier than three years prior to the date hereof; and no notice of objection of
the Commission to the use of such registration statement or any post-effective amendment thereto
pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order
suspending the effectiveness of the Registration Statement has been issued by the Commission and no
proceeding for that purpose or pursuant to Section 8A of the Securities Act against the Company or
related to the offering of the Securities has been initiated or, to the Company’s knowledge,
threatened by the Commission; as of the applicable effective date of the Registration Statement and
any amendment thereto, the Registration Statement complied and will comply in all material respects
with the Securities Act and the Trust Indenture Act of 1939, as amended, and the rules and
regulations of the Commission thereunder (collectively, the “Trust Indenture Act”), and did not and
will not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein not misleading; and as of
the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and
as of the Additional Closing Date, as the case may be, the Prospectus will not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; provided that the Company and the Guarantors make no
representation and warranty with respect to (i) that part of the Registration Statement that
constitutes the Statement of Eligibility and Qualification (Form T-1) of the Trustee under the
Trust Indenture Act or (ii) any statements or omissions made in reliance upon and in conformity
with information relating to any Underwriter furnished to the Company in writing by such
Underwriter through the Representatives expressly for use in the Registration Statement and the
Prospectus and any amendment or supplement thereto.
6
(e) Incorporated Documents. The documents incorporated by reference in the Registration
Statement, the Prospectus or the Time of Sale Information, when they were filed with the Commission
conformed in all material respects to the requirements of the Exchange Act and none of such
documents contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and any further documents so filed and
incorporated by reference in the Registration Statement, the Prospectus or the Time of Sale
Information, when such documents are filed with the Commission, will conform in all material
respects to the requirements of the Exchange Act and will not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were made, not
misleading.
(f) Financial Statements. The financial statements and the related notes thereto of the
Company and its consolidated subsidiaries included or incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus comply in all material respects with the
applicable requirements of the Securities Act and the Exchange Act, as applicable, and present
fairly in all material respects the financial position of the Company and its consolidated
subsidiaries as of the dates indicated and the results of their operations and the changes in their
cash flows for the periods specified; such financial statements have been prepared in conformity
with generally accepted accounting principles applied on a consistent basis throughout the periods
covered thereby; and the other financial information included or incorporated by reference in the
Registration Statement, the Time of Sale Information and the Prospectus has been derived from the
accounting records of the Company and its subsidiaries and presents fairly in all material respects
the information shown thereby.
(g) No Material Adverse Change. Since the date of the most recent financial statements of the
Company included or incorporated by reference in the Registration Statement, the Time of Sale
Information and the Prospectus, except in each case as otherwise disclosed in the Registration
Statement, the Time of Sale Information and the Prospectus, (i) there has not been any change in
the capital stock or long-term debt of the Company or any of its subsidiaries, or any dividend or
distribution of any kind declared, set aside for payment, paid or made by the Company on any class
of capital stock, or any material adverse change, or any development involving a prospective
material adverse change, in or affecting the business, properties, management, financial position,
stockholders’ equity, results of operations or prospects of the Company and its subsidiaries taken
as a whole; (ii) neither the Company nor any of its subsidiaries has entered into any transaction
or agreement that is material to the Company and its subsidiaries taken as a whole or incurred any
liability or obligation, direct or contingent, that is material to the Company and its subsidiaries
taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained any
material loss or interference with its business from fire, explosion, flood or other calamity,
whether or not covered by insurance, or from any labor disturbance or dispute or any action, order
or decree of any court or arbitrator or governmental or regulatory authority.
(h) Organization and Good Standing. The Company and each of its subsidiaries have been duly
organized and are validly existing and in good standing under the laws of their respective
jurisdictions of organization, are duly qualified to do business and are in
7
good standing in each jurisdiction in which their respective ownership or lease of property or
the conduct of their respective businesses requires such qualification, and have all power and
authority necessary to own or hold their respective properties and to conduct the businesses in
which they are engaged, except where the failure to be so qualified or have such power or authority
would not, individually or in the aggregate, have a material adverse effect on the business,
properties, management, financial position, stockholders’ equity, results of operations or
prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company
and the Guarantors of their obligations under the Securities, the Guarantees and the Conversion
Shares (a “Material Adverse Effect”). The Company does not own or control, directly or indirectly,
any corporation, association or other entity other than the entities listed in Annex A hereto (the
“subsidiaries”).
(i) Capitalization. The Company has an authorized capitalization as set forth in the
Registration Statement, the Time of Sale Information and the Prospectus under the heading
“Capitalization”; all the outstanding shares of capital stock of the Company have been duly and
validly authorized and issued and are fully paid and non-assessable and are not subject to any
pre-emptive or similar rights; except as described in or expressly contemplated by the Time of Sale
Information and the Prospectus, there are no outstanding rights (including, without limitation,
pre-emptive rights), warrants or options to acquire, or instruments convertible into or
exchangeable for, any shares of capital stock or other equity interest in the Company or any of its
subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind
relating to the issuance of any capital stock of the Company or any such subsidiary, any such
convertible or exchangeable securities or any such rights, warrants or options; the capital stock
of the Company conforms in all material respects to the description thereof contained in the
Registration Statement, the Time of Sale Information and the Prospectus; and all the outstanding
shares of capital stock or other equity interests of each subsidiary of the Company have been duly
and validly authorized and issued, are fully paid and non-assessable and are owned directly or
indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest,
restriction on voting or transfer or any other claim of any third party, except for (i) liens
existing under the Amended and Restated Credit Agreement, dated November 17, 2006, by and among the
Company, JPMorgan Chase Bank, N.A., as administrative agent, and each of the lenders thereto, as
amended by the First Amendment to Amended and Restated Credit Agreement, dated December 4, 2006, by
and among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and each of the lenders
thereto (together, the “Credit Agreement”) on the date hereof as set forth in the Registration
Statement, the Time of Sale Information and the Prospectus, (ii) liens existing under the Credit
Agreement, dated as of May 4, 2006 (the “DHS Credit Agreement”) among DHS Holding Company, DHS
Drilling Company, and JPMorgan Chase Bank, N.A., as administrative agent, and each of the lenders
thereto on the date hereof as set forth in the Registration Statement, the Time of Sale Information
and the Prospectus and (iii) as set forth in Annex A and disclosed in the Registration Statement,
the Time of Sale Information and the Prospectus.
(j) Due Authorization. The Company and each of the Guarantors has requisite corporate (or
other entity) right, power and authority to execute and deliver this Agreement, the Securities and
the Indenture (including each Guarantee set forth therein) (collectively, the “Transaction
Documents”), and the Company and each of the Guarantors have the requisite corporate (or other
entity) right, power and authority to perform their respective
8
obligations hereunder and thereunder; and, as of the Closing Date, all corporate, limited
liability company (or other entity) action required to be taken for the due and proper
authorization, execution, issuance and delivery of each of the Transaction Documents and the
consummation of the transactions contemplated hereby or by the Time of Sale Information and the
Prospectus has been or will have been duly and validly taken. The Company has requisite corporate
(or other entity) right, power and authority to issue and deliver the Conversion Shares.
(k) The Indenture. The Indenture has been duly authorized by the Company and each of the
Guarantors and, when duly executed and delivered in accordance with its terms by each of the
parties thereto, will constitute a valid and legally binding agreement of the Company and each of
the Guarantors enforceable against the Company and each of the Guarantors in accordance with its
terms, except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws
affecting the enforcement of creditors’ rights generally or by equitable principles relating to
enforceability (collectively, the “Enforceability Exceptions”); and on the Closing Date, the
Indenture will have been duly qualified under the Trust Indenture Act.
(l) The Securities and the Guarantees. The Securities have been duly authorized by the
Company and, when duly executed, authenticated, issued and delivered as provided in the Indenture
and paid for as provided herein, will be duly and validly issued and outstanding and will
constitute valid and legally binding obligations of the Company enforceable against the Company in
accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the
benefits of the Indenture; and the Guarantees have been duly authorized by each of the Guarantors
and, when the Securities have been duly executed, authenticated, issued and delivered as provided
in the Indenture and paid for as provided herein, will be valid and legally binding obligations of
each of the Guarantors, enforceable against each of the Guarantors in accordance with their terms,
subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture.
The Securities will be convertible into Common Stock in accordance with their terms and the terms
of the Indenture.
(m) The Conversion Shares. The shares of Common Stock issuable upon conversion of the
Securities have been duly and validly authorized and are free of preemptive rights and, when issued
and delivered upon such conversion in accordance with the terms of the Indenture, will be duly and
validly authorized and issued, fully paid and non-assessable and free and clear of all liens,
encumbrances, equities or claims; the Board of Directors of the Company has duly and validly
adopted resolutions reserving such shares of Common Stock for issuance upon conversion.
(n) Underwriting Agreement. This Agreement has been duly authorized, executed and delivered
by the Company and each of the Guarantors.
(o) Descriptions of the Transaction Documents. The description of each Transaction Document
contained in the Registration Statement, the Time of Sale Information and the Prospectus is
accurate in all material respects.
(p) No Violation or Default. Neither the Company nor any of its subsidiaries is (i) in
violation of its charter or by-laws or similar organizational documents; (ii) in default, and
9
no event has occurred that, with notice or lapse of time or both, would constitute such a
default, in the due performance or observance of any term, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the
Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is
bound or to which any of the property or assets of the Company or any of its subsidiaries is
subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of
any court or arbitrator or governmental or regulatory authority, except, in the case of clauses
(ii) and (iii) above, for any such default or violation that would not, individually or in the
aggregate, have a Material Adverse Effect.
(q) No Conflicts. The execution, delivery and performance by the Company and each of the
Guarantors of each of the Transaction Documents to which it is a party, the issuance,
authentication, sale and delivery of the Securities and the Guarantees and the Common Stock
issuable upon conversion of the Securities in accordance with the terms and conditions of the
Indenture and compliance by the Company and each of the Guarantors with all the provisions of the
Transaction Documents and the consummation of the transactions contemplated by the Transaction
Documents or the Time of Sale Information and the Prospectus will not (i) conflict with or result
in a breach or violation of any of the terms or provisions of, or constitute a default under, or
result in the creation or imposition of any lien, charge or encumbrance upon any property or assets
of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which the Company or any of its subsidiaries is a
party or by which the Company or any of its subsidiaries is bound or to which any of the property
or assets of the Company or any of its subsidiaries is subject, (ii) result in any violation of the
provisions of the charter or by-laws or similar organizational documents of the Company or any of
its subsidiaries or (iii) result in the violation of any law or statute or any judgment, order,
rule or regulation of any court or arbitrator or governmental or regulatory authority.
(r) No Consents Required. No consent, approval, authorization, order, registration or
qualification of or with any court or arbitrator or governmental or regulatory authority is
required for the execution, delivery and performance by the Company and each of the Guarantors of
each of the Transaction Documents to which it is a party, the issuance, authentication, sale and
delivery of the Securities and the Guarantees and the Common Stock issuable upon conversion of the
Securities in accordance with the terms and conditions of the Indenture and compliance by the
Company and each of the Guarantors with all the provisions of the Transaction Documents and the
consummation of the transactions contemplated by the Transaction Documents or the Time of Sale
Information and the Prospectus, except for the registration of the Securities and the Guarantees
under the Securities Act, the qualification of the Indenture under the Trust Indenture Act and such
consents, approvals, authorizations, orders and registrations or qualifications as may be required
under applicable state securities laws in connection with the purchase and distribution of the
Securities by the Underwriters.
(s) Legal Proceedings. Except as described in the Registration Statement, the Time of Sale
Information and the Prospectus, there are no legal, governmental or regulatory investigations,
actions, suits or proceedings pending to which the Company or any of its subsidiaries is or may be
a party or to which any property of the Company or any of its subsidiaries is or may be the subject
that, individually or in the aggregate, would reasonably be
10
expected to have a Material Adverse Effect; to the knowledge of the Company and each of the
Guarantors, no such investigations, actions, suits or proceedings are threatened or contemplated by
any governmental or regulatory authority or threatened by others; and (i) there are no current or
pending legal, governmental or regulatory actions, suits or proceedings that are required under the
Securities Act to be described in the Registration Statement that are not so described in the
Registration Statement, the Time of Sale Information and the Prospectus and (ii) there are no
statutes, regulations or contracts or other documents that are required under the Securities Act to
be described in the Registration Statement or the Prospectus or filed as exhibits to the
Registration Statement that are not so filed as exhibits to the Registration Statement or described
in the Registration Statement, the Time of Sale Information and the Prospectus.
(t) Independent Accountants. KPMG LLC, who have certified certain financial statements of the
Company and its subsidiaries, is an independent registered public accounting firm with respect to
the Company and its subsidiaries within the applicable rules and regulations adopted by the
Commission and the Public Company Accounting Oversight Board (United States) and as required by the
Securities Act.
(u) Title to Real and Personal Property. The Company and its subsidiaries have good and valid
title to, or have valid rights to lease or otherwise use, in each case in accordance with industry
custom and standard, all items of real and personal property that are material to the respective
businesses of the Company and its subsidiaries, in each case free and clear of all liens,
encumbrances, claims and defects and imperfections of title except those that (i) exist under the
Credit Agreement or the DHS Credit Agreement on the date hereof as set forth in the Registration
Statement, the Time of Sale Information and the Prospectus, (ii) do not materially interfere with
the use made and proposed to be made of such property by the Company and its subsidiaries or (iii)
would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect.
(v) Title to Intellectual Property. The Company and its subsidiaries own or possess adequate
rights to use all material patents, patent applications, trademarks, service marks, trade names,
trademark registrations, service xxxx registrations, copyrights, licenses and know-how (including
trade secrets and other unpatented and/or unpatentable proprietary or confidential information,
systems or procedures) necessary for the conduct of their respective businesses; and the conduct of
their respective businesses will not conflict in any material respect with any such rights of
others, and the Company and its subsidiaries have not received any notice of any claim of
infringement or conflict with any such rights of others.
(w) No Undisclosed Relationships. No relationship, direct or indirect, exists between or
among the Company or any of its subsidiaries, on the one hand, and the directors, officers,
stockholders, customers or suppliers of the Company or any of its subsidiaries, on the other, that
is required by the Securities Act to be described in the Registration Statement and the Prospectus
and that is not so described in such documents and in the Time of Sale Information.
(x) Investment Company Act. Neither the Company nor any of the Guarantors is and, after
giving effect to the offering and sale of the Securities and the application of the proceeds
thereof as described in the Registration Statement, the Time of Sale Information and the
Prospectus, none of them will be required to register as an “investment company” or an entity
11
“controlled” by an “investment company” within the meaning of the Investment Company Act of
1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the
“Investment Company Act”).
(y) Taxes. The Company and its subsidiaries have paid all material federal, state, local and
foreign taxes and filed all material tax returns required to be paid or filed through the date
hereof; and except as otherwise disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, there is no material tax deficiency that has been, or would
reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of
their respective properties or assets.
(z) Licenses and Permits. The Company and its subsidiaries possess all licenses,
certificates, permits and other authorizations issued by, and have made all declarations and
filings with, the appropriate federal, state, local or foreign governmental or regulatory
authorities that are necessary for the ownership or lease of their respective properties or the
conduct of their respective businesses as described in the Registration Statement, the Time of Sale
Information and the Prospectus, except where the failure to possess or make the same would not,
individually or in the aggregate, have a Material Adverse Effect; and except as described in the
Registration Statement, the Time of Sale Information and the Prospectus, neither the Company nor
any of its subsidiaries has received notice of any revocation or modification of any such license,
certificate, permit or authorization or has any reason to believe that any such license,
certificate, permit or authorization will not be renewed in the ordinary course.
(aa) No Labor Disputes. No labor disturbance by or dispute with employees of the Company or
any of its subsidiaries exists or, to the knowledge of the Company and each of the Guarantors, is
contemplated or threatened and neither the Company nor any Guarantor is aware of any existing or
imminent labor disturbance by, or dispute with, the employees of any of the Company’s or any of the
Company’s subsidiaries’ principal suppliers, contractors or customers, except as would not have a
Material Adverse Effect.
(bb) Compliance with Environmental Laws. (i) The Company and its subsidiaries (x) are, and at
all prior relevant times were, in compliance with any and all applicable federal, state, local and
foreign laws, rules, regulations, requirements, decisions and orders relating to the protection of
human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or
contaminants (collectively, “Environmental Laws”); (y) have received and are in compliance with all
permits, licenses, certificates or other authorizations or approvals required of them under
applicable Environmental Laws to conduct their respective businesses; and (z) have not received
notice of any actual or potential liability for the investigation or remediation of any disposal or
release of hazardous or toxic substances or wastes, pollutants or contaminants, and (ii) there are
no costs or liabilities associated with Environmental Laws of or relating to the Company or its
subsidiaries, except for any such failure to comply, or failure to receive required permits,
licenses or approvals, or cost or liability, as would not, individually or in the aggregate, have a
Material Adverse Effect.
(cc) Hazardous Substances. There has been no storage, generation, transportation, handling,
treatment, disposal, discharge, emission, or other release of any kind of toxic wastes or hazardous
substances, including, but not limited to, any naturally occurring
12
radioactive materials, brine, drilling mud, crude oil, natural gas liquids and other petroleum
materials, by, due to or caused by the Company or any of its subsidiaries (or, to the best of the
Company’s knowledge, any other entity (including any predecessor) for whose acts or omissions the
Company or any of its subsidiaries is or would reasonably be expected to be liable) upon any of the
property now or previously owned or leased by the Company or any of its subsidiaries, or upon any
other property, in violation of any Environmental Laws or in a manner or to a location that would
reasonably be expected to give rise to any liability under any Environmental Laws, except for any
violation or liability which would not, individually or in the aggregate, have a Material Adverse
Effect.
(dd) Certain Environmental Proceedings and Capital Expenditures. Except as described in the
Registration Statement, the Time of Sale Information and the Prospectus, (i) without limitation to
Section 3(s) hereof, there are no proceedings that are pending, or that are known to be
contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which
a governmental entity is also a party, other than such proceedings regarding which it is reasonably
believed no monetary sanctions of $100,000 or more will be imposed, and (ii) none of the Company
and its subsidiaries anticipates material capital expenditures relating to any Environmental Laws.
(ee) Compliance with ERISA. (i) Each employee benefit plan, within the meaning of Section
3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), for which the
Company or any member of its “Controlled Group” (defined as any organization which is a member of a
controlled group of corporations within the meaning of Section 414 of the Internal Revenue Code of
1986, as amended (the “Code”)) would have any liability (each, a “Plan”) has been maintained in
compliance with its terms and the requirements of any applicable statutes, orders, rules and
regulations, including but not limited to ERISA and the Code; (ii) no prohibited transaction,
within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect
to any Plan excluding transactions effected pursuant to a statutory or administrative exemption;
(iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302
of ERISA, no “accumulated funding deficiency” as defined in Section 412 of the Code, whether or not
waived, has occurred or is reasonably expected to occur; (iv) the fair market value of the assets
of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on
those assumptions used to fund such Plan); (v) no “reportable event” (within the meaning of Section
4043(c) of ERISA) has occurred or is reasonably expected to occur; and (vi) neither the Company nor
any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability
under Title IV of ERISA (other than contributions to the Plan or premiums to the PBGC, in the
ordinary course and without default) in respect of a Plan (including a “multiemployer plan”, within
the meaning of Section 4001(a)(3) of ERISA); except where those events or conditions described in
clauses (i) through (vi) above would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.
(ff) Disclosure Controls. The Company and its subsidiaries maintain an effective system of
“disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that is
designed to ensure that information required to be disclosed by the Company in reports that it
files or submits under the Exchange Act is recorded, processed, summarized and reported within the
time periods specified in the Commission’s rules and forms,
13
including controls and procedures designed to ensure that such information is accumulated and
communicated to the Company’s management as appropriate to allow timely decisions regarding
required disclosure. The Company and its subsidiaries have carried out evaluations of the
effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the
Exchange Act.
(gg) Accounting Controls. The Company and its subsidiaries maintain systems of “internal
control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply
with the requirements of the Exchange Act and have been designed by, or under the supervision of,
their respective principal executive and principal financial officers, or persons performing
similar functions, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles, including, but not limited to internal accounting controls
sufficient to provide reasonable assurance that (i) transactions are executed in accordance with
management’s general or specific authorizations; (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with generally accepted accounting
principles and to maintain asset accountability; (iii) access to assets is permitted only in
accordance with management’s general or specific authorization; and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences. Except as disclosed in the
Registration Statement, the Time of Sale Information and the Prospectus, there are no material
weaknesses in the Company’s internal controls. The Company’s auditors and the Audit Committee of
the Board of Directors of the Company have been advised of: (i) all significant deficiencies and
material weaknesses in the design or operation of internal controls over financial reporting which
are reasonably likely to adversely affect the Company’s ability to record, process, summarize, and
report financial information; and (ii) any fraud, whether or not material, that involves management
or other employees who have a significant role in the Company’s internal controls over financial
reporting.
(hh) Insurance. The Company and its subsidiaries have insurance covering their respective
properties, operations, personnel and businesses, including business interruption insurance, which
insurance is in amounts and insures against such losses and risks as are customary in the oil and
gas business and adequate, in all material respects, to protect the Company and its subsidiaries
and their respective businesses; and neither the Company nor any of its subsidiaries has (i)
received notice from any insurer or agent of such insurer that capital improvements or other
expenditures are required or necessary to be made in order to continue such insurance or (ii) any
reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may
be necessary to continue its business.
(ii) No Unlawful Payments. Neither the Company nor any of its subsidiaries nor, to the
knowledge of the Company and each of the Guarantors, any director, officer, agent, employee or
other person acting on behalf of the Company or any of its subsidiaries has (i) used any corporate
funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to
political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic
government official or employee from corporate funds; (iii) violated or is in violation
14
of any provision of the Foreign Corrupt Practices Act of 1977; or (iv) made any bribe, rebate,
payoff, influence payment, kickback or other unlawful payment.
(jj) Compliance with Money Laundering Laws. The operations of the Company and its
subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or
enforced by any governmental agency (collectively, the “Money Laundering Laws”) and no action, suit
or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is
pending or, to the knowledge of the Company, threatened.
(kk) Compliance with OFAC. None of the Company, any of its subsidiaries or, to the knowledge
of the Company, any director, officer, agent, employee or Affiliate of the Company or any of its
subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Department of the Treasury (“OFAC”); and the Company will not directly
or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other person or
entity, for the purpose of financing the activities of any person currently subject to any U.S.
sanctions administered by OFAC.
(ll) Solvency. On the Closing Date or the Additional Closing Date, as the case may be, and
immediately after giving effect to the issuance of the Securities and the consummation of the other
transactions related thereto (as described in the Registration Statement, Time of Sale Information
and the Prospectus) the Company and the Guarantors, on a consolidated basis, will be Solvent. As
used in this paragraph, the term “Solvent” means, with respect to a particular date, that on such
date (i) the present fair market value (or present fair saleable value) of the assets of the
Company and the Guarantors, on a consolidated basis, is not less than the total amount required to
pay the probable liabilities of the Company and the Guarantors, on a consolidated basis, on their
total existing debts and liabilities (including contingent liabilities) as they become absolute and
matured; (ii) the Company and the Guarantors, on a consolidated basis, are able to realize upon
their assets and pay their debts and other liabilities, contingent obligations and commitments as
they mature and become due in the normal course of business; (iii) assuming consummation of the
issuance of the Securities as contemplated by this Agreement, the Registration Statement, the Time
of Sale Information and the Prospectus, the Company has not incurred, and does not propose to
incur, debts or liabilities that would be beyond its ability to pay as such debts and other
liabilities mature; (iv) the Company and the Guarantors, on a consolidated basis, are not engaged
in any business or transaction, and do not propose to engage in any business or transaction, for
which their property would constitute unreasonably small capital after giving due consideration to
the prevailing practice in the industry in which the Company and the Guarantors are engaged; and
(v) the Company or such Guarantor, as the case may be, is not a defendant in any civil action that
would result in a judgment that the Company or such Guarantor, as the case may be, is or would
become unable to satisfy.
15
(mm) No Restrictions on Subsidiaries. No subsidiary of the Company is currently prohibited,
directly or indirectly, under any agreement or other instrument to which it is a party or is
subject, from paying any dividends to the Company, from making any other distribution on such
subsidiary’s capital stock, from repaying to the Company any loans or advances to such subsidiary
from the Company or from transferring any of such subsidiary’s properties or assets to the Company
or any other subsidiary of the Company, except pursuant to the Credit Agreement, the DHS Credit
Agreement, and the Indenture dated as of March 15, 2005 (the “2005 Indenture”), among Delta
Petroleum Corporation, the guarantors named therein and U.S. Bank National Association, as trustee,
relating to the Company’s 7% Senior Notes due 2015.
(nn) No Broker’s Fees. Neither the Company nor any of its subsidiaries is a party to any
contract, agreement or understanding with any person (other than this Agreement) that would give
rise to a valid claim against the Company or any of its subsidiaries or any Underwriter for a
brokerage commission, finder’s fee or like payment in connection with the offering and sale of the
Securities.
(oo) No Registration Rights. Except for rights with respect to shares that have been
registered for resale pursuant to effective registration statements as described in the
Registration Statement, the Time of Sale Information and the Prospectus, no person has the right to
require the Company or any of its subsidiaries to register any securities for sale under the
Securities Act by reason of the filing of the Registration Statement with the Commission or the
issuance and sale of the Securities.
(pp) No Stabilization. Neither the Company nor any Guarantor has taken, directly or
indirectly, any action designed to or that could reasonably be expected to cause or result in any
stabilization or manipulation of the price of the Securities.
(qq) Business with Cuba. The Company has complied with all provisions of Section 517.075,
Florida Statutes (Chapter 92-198, Laws of Florida) relating to doing business with the Government
of Cuba or with any person or affiliate located in Cuba.
(rr) Margin Rules. Neither the issuance, authentication, sale and delivery of the Securities
and the Guarantees nor the application of the proceeds thereof by the Company as described in the
Registration Statement, the Time of Sale Information and the Prospectus will violate Regulation T,
U or X of the Board of Governors of the Federal Reserve System or any other regulation of such
Board of Governors.
(ss) Forward-Looking Statements. No forward-looking statement (within the meaning of Section
27A of the Securities Act and Section 21E of the Exchange Act) contained in the Registration
Statement, the Time of Sale Information and the Prospectus has been made or reaffirmed without a
reasonable basis or has been disclosed other than in good faith.
(tt) Statistical and Market Data. Nothing has come to the attention of the Company that has
caused the Company to believe that the statistical and market-related data
included in the Registration Statement, the Time of Sale Information and the Prospectus is not
based on or derived from sources that are reliable and accurate in all material respects.
16
(uu) Reserve Report Data. The oil and gas reserve estimates of the Company and its
subsidiaries for the years ended June 30, 2003 and 2004, the six months ended December 31, 2005 and
the year ended December 31, 2006 contained in the Registration Statement, the Time of Sale
Information and the Prospectus are derived from reports that have been prepared by independent
petroleum consulting firms as set forth in the Registration Statement, the Time of Sale Information
and the Prospectus, to the Company’s knowledge, such reserve estimates fairly reflect the oil and
gas reserves of the Company and its subsidiaries at the dates indicated in the Registration
Statement, the Time of Sale Information and the Prospectus and were prepared in accordance with the
Commission guidelines applied on a consistent basis throughout the periods involved.
(vv) Independent Reserve Engineering Firms. Xxxxx X. Xxxxx Associates, Inc. and Xxxxxx
Associates are each independent reserve engineers with respect to the Company and its subsidiaries
and for the periods set forth in the Registration Statement, the Time of Sale Information and the
Prospectus.
(ww) Xxxxxxxx-Xxxxx Act. There is and has been no failure on the part of the Company or any
of the Company’s directors or officers, in their capacities as such, to comply in all material
respects with any provision of the Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations
promulgated in connection therewith, including Section 402 related to loans and Sections 302 and
906 related to certifications.
(xx) Status under the Securities Act. The Company is not an “ineligible issuer” and is a
“well-known seasoned issuer,” in each case as defined under the Securities Act, in each case at the
times specified in the Securities Act in connection with the offering of the Securities. The
Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the
Securities Act or will pay such fees within the time period required by such rule (without giving
effect to the proviso therein) and in any event prior to the Closing Date.
(yy) Beneficial Owners. To the Company’s knowledge, the Company has no beneficial owner
(as defined in Rules 13d-3 and 13d-5 under the Exchange Act) of more than 5% of its Common
Stock other than as set forth in the Company’s Proxy Statement on Schedule 14A filed with the
Commission on December 28, 2006.
4. Further Agreements of the Company and the Guarantors. The Company and each of the
Guarantors jointly and severally covenants and agrees with each Underwriter that:
(a) Required Filings. The Company and the Guarantors will file the final Prospectus with the
Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the
Securities Act, will file any Issuer Free Writing Prospectus (including the Term Sheet in the form
of Annex C hereto) to the extent required by Rule 433 under the Securities Act; and will file
promptly all reports and any definitive proxy or information statements required to be filed by the
Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act
subsequent to the date of the Prospectus
and for so long as the delivery of a prospectus is required in connection with the offering or
sale of the Securities; and the Company will furnish copies of the Prospectus and each Issuer Free
Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City
17
prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this
Agreement in such quantities as the Representatives may reasonably request. The Company will pay
the registration fees for this offering within the time period required by Rule 456(b)(i) under the
Securities Act prior to the Closing Date.
(b) Delivery of Copies. The Company will deliver, without charge, (i) to the Representatives,
three signed copies of the Registration Statement as originally filed and each amendment thereto,
in each case including all exhibits and consents filed therewith and documents incorporated by
reference therein; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement
as originally filed and each amendment thereto (without exhibits) and (B) during the Prospectus
Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and
supplements thereto and documents incorporated by reference therein) and each Issuer Free Writing
Prospectus as the Representatives may reasonably request. As used herein, the term “Prospectus
Delivery Period” means such period of time after the first date of the public offering of the
Securities as in the opinion of counsel for the Underwriters a prospectus relating to the
Securities is required by law to be delivered (or required to be delivered but for Rule 172 under
the Securities Act) in connection with sales of the Securities by any Underwriter or dealer.
(c) Amendments or Supplements, Issuer Free Writing Prospectuses. Before preparing, using,
authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before
filing any amendment or supplement to the Registration Statement or the Prospectus, the Company
will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer
Free Writing Prospectus, amendment or supplement for review and will not prepare, use, authorize,
approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed
amendment or supplement to which the Representatives reasonably object.
(d) Notice to the Representatives. The Company will advise the Representatives promptly, and
confirm such advice in writing, (i) when any amendment to the Registration Statement has been filed
or becomes effective; (ii) when any supplement to the Prospectus or any Issuer Free Writing
Prospectus or any amendment to the Prospectus has been filed; (iii) of any request by the
Commission for any amendment to the Registration Statement or any amendment or supplement to the
Prospectus or the receipt of any comments from the Commission relating to the Registration
Statement or any other request by the Commission for any additional information; (iv) of the
issuance by the Commission of any order suspending the effectiveness of the Registration Statement
or preventing or suspending the use of any Preliminary Prospectus, the Time of Sale Information or
the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to
Section 8A of the Securities Act; (v) of the occurrence of any event within the Prospectus Delivery
Period as a result of which the Prospectus, the Time of Sale Information or any Issuer Free Writing
Prospectus as then amended or supplemented would include any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances existing when the Prospectus, the Time of
Sale Information or any such
Issuer Free Writing Prospectus is delivered to a purchaser, not misleading; (vi) of the
receipt by the Company of any notice of objection of the Commission to the use of the Registration
Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the
18
Securities
Act; and (vii) of the receipt by the Company of any notice with respect to any suspension of the
qualification of the Securities for offer and sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose; and the Company will use its best efforts to
prevent the issuance of any such order suspending the effectiveness of the Registration Statement,
preventing or suspending the use of any Preliminary Prospectus, the Time of Sale Information or the
Prospectus or suspending any such qualification of the Securities and, if any such order is issued,
will obtain as soon as possible the withdrawal thereof.
(e) Ongoing Compliance. (1) If during the Prospectus Delivery Period (i) any event shall
occur or condition shall exist as a result of which the Prospectus as then amended or supplemented
would include any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the
circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii) it
is necessary to amend or supplement the Prospectus to comply with law, the Company will immediately
notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file
with the Commission and furnish to the Underwriters and to such dealers as the Representatives may
designate, such amendments or supplements to the Prospectus as may be necessary so that the
statements in the Prospectus as so amended or supplemented will not, in the light of the
circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that
the Prospectus will comply with law and (2) if at any time prior to the Closing Date (i) any event
shall occur or condition shall exist as a result of which the Time of Sale Information as then
amended or supplemented would include any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the circumstances
existing when the Time of Sale Information is delivered to a purchaser, not misleading or (ii) it
is necessary to amend or supplement the Time of Sale Information to comply with law, the Company
will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph
(c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to
such dealers as the Representatives may designate, such amendments or supplements to the Time of
Sale Information as may be necessary so that the statements in the Time of Sale Information as so
amended or supplemented will not, in the light of the circumstances existing when the Time of Sale
Information is delivered to a purchaser, be misleading or so that the Time of Sale Information will
comply with law.
(f) Blue Sky Compliance. The Company will qualify the Securities for offer and sale under the
securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request
and will continue such qualifications in effect so long as required for distribution of the
Securities; provided that neither the Company nor any of the Guarantors shall be required
to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such
jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent
to service of process in any such jurisdiction or (iii) subject itself to taxation in any such
jurisdiction if it is not otherwise so subject.
(g) Earning Statement. The Company will make generally available to its security holders and
the Representatives as soon as practicable an earning statement that satisfies the provisions of
Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering
a period of at least twelve months beginning with the first
19
fiscal quarter of the Company occurring
after the “effective date” (as defined in Rule 158) of the Registration Statement.
(h) Clear Market. Except as provided in Section 4(i), during the period from the date hereof
through and including the date that is 90 days after the date hereof, the Company and each of the
Guarantors will not, without the prior written consent of X.X. Xxxxxx Securities Inc., offer, sell,
contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Company or
any of the Guarantors and having a tenor of more than one year.
(i) Clear Market. For a period of 90 days after the date of the initial public offering of
the Securities, the Company will not (i) offer, pledge, announce the intention to sell, sell,
contract to sell, sell any option or contract to purchase, purchase any option or contract to sell,
grant any option, right or warrant to purchase or otherwise transfer or dispose of, directly or
indirectly, any shares of Common Stock or any securities convertible into or exercisable or
exchangeable for Common Stock or (ii) enter into any swap or other agreement that transfers, in
whole or in part, any of the economic consequences of ownership of the Common Stock, whether any
such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock
or such other securities, in cash or otherwise, without the prior written consent of the
Representatives, other than (i) the Securities to be sold hereunder, (ii) the sale of the Company’s
Common Stock to the underwriters therefor in the Company’s concurrent and separate Common Stock
offering, (iii) any shares of Common Stock of the Company issued upon the exercise of options
granted under existing employee stock option plans, (iv) 1,500,000 shares of Common Stock to be
issued pursuant to the Company’s 2007 Performance and Equity Incentive Plan (the “2007 Incentive
Plan”) to the Company’s executive officers as contemplated by the Company’s Proxy Statement on
Schedule 14A filed December 28, 2006, which shares of Common Stock will be subject to the lock-up
agreements described in Section 6(p), and (v) up to 1,300,000 additional shares of Common Stock of
the Company issuable under the Company’s 2007 Incentive Plan, which was approved by the Company’s
stockholders on January 29, 2007. Notwithstanding the foregoing, if (1) during the last
17 days of the 90-day restricted period, the Company issues an earnings release or material news or
a material event relating to the Company occurs; or (2) prior to the expiration of the 90-day
restricted period, the Company announces that it will release earnings results during the 16-day
period beginning on the last day of the 90-day period, the restrictions imposed by this Agreement
shall continue to apply until the expiration of the 18-day period beginning on the issuance of the
earnings release or the occurrence of the material news or material event.
(j) Use of Proceeds. The Company will apply the net proceeds from the sale of the Securities
as described in the Registration Statement, the Time of Sale Information and the Prospectus under
the heading “Use of proceeds”.
(k) No Stabilization. Neither the Company nor any of the Guarantors will take, directly or
indirectly, any action designed to or that could reasonably be expected to cause or result in any
stabilization or manipulation of the price of the Securities.
(l) DTC. The Securities shall be eligible for clearance and settlement through DTC.
20
(m) Exchange Listing. The Company will use its best efforts to supplementally list the
Conversion Shares on the National Association of Securities Dealers Automated Quotations Global
Market (the “NASDAQ Global Market”).
(n) Conversion Shares. The Company will reserve and keep available at all times, free of
preemptive rights, the maximum number of Conversion Shares.
(o) Conversion Price. Between the date hereof and the Closing Date, the Company will not do
or authorize any act or thing that would result in an adjustment of the conversion price or
conversion rate of the Securities.
(p) Reports. So long as the Securities are outstanding, the Company will make available to
the Representatives, as soon as they are available, copies of all reports or other communications
(financial or other) furnished to holders of the Securities, and copies of any reports and
financial statements furnished to or filed with the Commission or any national securities exchange
or automatic quotation system.
(q) Record Retention. The Company will, pursuant to reasonable procedures developed in good
faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission
in accordance with Rule 433 under the Securities Act.
5. Certain Agreements of the Underwriters. Each Underwriter hereby represents and
agrees that:
(a) It has not and will not use, authorize use of, refer to, or participate in the planning
for use of, any “free writing prospectus”, as defined in Rule 405 under the Securities Act (which
term includes use of any written information furnished to the Commission by the Company or any
Guarantor and not incorporated by reference into the Registration Statement and any press release
issued by the Company or any Guarantor) other than (i) a free writing prospectus that contains no
“issuer information” (as defined in Rule 433(h)(2) under the Securities Act) that was not included
(including through incorporation by reference) in the Preliminary Prospectus or a previously filed
Issuer Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex B or
prepared pursuant to Section 3(c) or Section 4(c) above, or (iii) any free writing prospectus
prepared by such underwriter and approved by the Company in advance in writing (each such free
writing prospectus referred to in clauses (i) or (iii), an “Underwriter Free Writing Prospectus”).
Notwithstanding the foregoing, the Underwriters may use a term sheet substantially in the form
attached as Annex C hereto without the consent of the Company or any Guarantor.
(b) It has not and will not distribute any Underwriter Free Writing Prospectus referred to in
clause (a)(i) in a manner reasonably designed to lead to its broad unrestricted dissemination.
(c) It has not and will not, without the prior written consent of the Company, use any free
writing prospectus that contains the final terms of the Securities unless such terms have
previously been included in a free writing prospectus filed with the Commission.
21
(d) It will, pursuant to reasonable procedures developed in good faith, retain copies of each
free writing prospectus used or referred to by it, in accordance with Rule 433 under the Securities
Act.
(e) It is not subject to any pending proceeding under Section 8A of the Securities Act with
respect to the offering (and will promptly notify the Company if any such proceeding against it is
initiated during the Prospectus Delivery Period).
6. Conditions of Underwriters’ Obligations. The obligation of each Underwriter to
purchase the Firm Securities on the Closing Date or the Additional Securities on the Additional
Closing Date, as the case may be, as provided herein is subject to the performance by the Company
and each of the Guarantors of their respective covenants and other obligations hereunder and to the
following additional conditions:
(a) Registration Compliance; No Stop Order. No order suspending the effectiveness of the
Registration Statement shall be in effect, and no proceeding for such purpose, pursuant to Rule
401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened
by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely
filed with the Commission under the Securities Act (in the case of an Issuer Free Writing
Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with
Section 4(a) hereof; and all requests by the Commission for additional information shall have been
complied with to the reasonable satisfaction of the Representatives.
(b) Representations and Warranties. The representations and warranties of the Company and the
Guarantors contained herein shall be true and correct on the date hereof and on and as of the
Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company,
the Guarantors and their respective officers made in any certificates delivered pursuant to this
Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date,
as the case may be.
(c) No Downgrade. Subsequent to the execution and delivery of this Agreement, (i) no
downgrading shall have occurred in the rating accorded the Securities or any other debt securities
or preferred stock issued or guaranteed by the Company or any of its subsidiaries by any
“nationally recognized statistical rating organization”, as such term is defined by the Commission
for purposes of Rule 436(g)(2) under the Securities Act and (ii) no such organization shall have
publicly announced that it has under surveillance or review, or has changed its outlook with
respect to, its rating of the Securities or any other debt securities or preferred stock issued or
guaranteed by the Company or any of its subsidiaries (other than an announcement with positive
implications of a possible upgrading).
(d) No Material Adverse Change. No event or condition of a type described in Section 3(g)
hereof shall have occurred or shall exist, which event or condition is not
described in the Time of Sale Information (excluding any amendment or supplement thereto) and
the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the
judgment of the Representatives makes it impracticable or inadvisable to proceed with the offering,
sale or delivery of the Securities and the Guarantees on the Closing Date or the
22
Additional Closing
Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Time
of Sale Information and the Prospectus.
(e) Officers’ Certificates. The Representatives shall have received on and as of the Closing
Date or the Additional Closing Date, as the case may be, a certificate of the Company’s chief
financial officer or chief accounting officer of the Company and one additional senior executive
officer of the Company who is satisfactory to the Representatives and a certificate of two
executive officers of each Guarantor who have specific knowledge of such Guarantor’s financial
matters and are satisfactory to the Representatives (i) confirming that such officers have
carefully reviewed the Registration Statement, the Time of Sale Information and the Prospectus and,
to the knowledge of such officers, the representations set forth in Sections 3(b) and 3(d) hereof
are true and correct, (ii) confirming that the other representations and warranties of the Company
and each of the Guarantors, as applicable, in this Agreement are true and correct and that the
Company and each of the Guarantors, as applicable, have complied with all agreements and satisfied
all conditions on their part to be performed or satisfied hereunder at or prior to such Closing
Date, (iii) confirming that the Company and its subsidiaries are in compliance with the financial
covenants and other covenants of the Credit Agreement, the DHS Credit Agreement, and the 2005
Indenture and (iv) to the effect set forth in paragraphs (a), (c) and (d) above.
(f) Comfort Letters. On the date of this Agreement and on the Closing Date or the Additional
Closing Date, as the case may be, KPMG LLC shall have furnished to the Representatives, at the
request of the Company, letters, dated the respective dates of delivery thereof and addressed to
the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing
statements and information of the type customarily included in accountants’ “comfort letters” to
underwriters with respect to the financial statements and certain financial information contained
or incorporated by reference in the Registration Statement, the Time of Sale Information and the
Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date,
as the case may be, shall use a “cut-off” date no more than three business days prior to such
Closing Date or such Additional Closing Date, as the case may be.
(g) Reserve Report Confirmation Letters. On the date of this Agreement and on the Closing
Date or the Additional Closing Date, as the case may be, each of Xxxxx X. Xxxxx Associates, Inc.
and Xxxxxx Associates, Inc. shall have furnished to the Representative, at the request of the
Company, reserve report confirmation letters, dated the respective dates of delivery thereof and
addressed to the Underwriters, in form and substance reasonably satisfactory to the
Representatives, containing statements and information of the type customarily included in such
letters to underwriters with respect to the oil and gas reserve and other operational information
of the Company and its subsidiaries contained in the Registration Statement, the Time of Sale
Information and the Prospectus.
(h) Opinion of Counsel for the Company and the Guarantors. Xxxxx Xxxxxx & Xxxxxx LLP, counsel
for the Company and the Guarantors, shall have furnished to the Representatives, at the request of
the Company, their written opinion, dated the Closing Date or the Additional Closing Date, as the
case may be, and addressed to the Underwriters, in form and
23
substance reasonably satisfactory to
the Representatives, substantially to the effect set forth in Annex D hereto.
(i) Opinion of General Counsel. Xxxxxxx X. Xxxxxxxx, Executive Vice President, General
Counsel and Secretary of the Company, shall have furnished to the Representatives, at the request
of the Company, his written opinion, dated the Closing Date or the Additional Closing Date, as the
case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to
the Representatives, substantially to the effect set forth in Annex E hereto.
(j) Opinion of Counsel for the Underwriters. The Representatives shall have received on and
as of the Closing Date or the Additional Closing Date, as the case may be, an opinion of Xxxxxxx
Xxxxxxx & Xxxxxxxx LLP, counsel for the Underwriters, with respect to such matters as the
Representatives may reasonably request, and such counsel shall have received such documents and
information as they may reasonably request to enable them to pass upon such matters.
(k) No Legal Impediment to Issuance. No action shall have been taken and no statute, rule,
regulation or order shall have been enacted, adopted or issued by any federal, state or foreign
governmental or regulatory authority that would, as of the Closing Date or the Additional Closing
Date, as the case may be, prevent the issuance or sale of the Securities or the issuance or sale of
the Guarantees or the issuance of the Conversion Shares; and no injunction or order of any federal,
state or foreign court shall have been issued that would, as of the Closing Date or the Additional
Closing Date, as the case may be, prevent the issuance or sale of the Securities or the issuance or
sale of the Guarantees or the issuance of the Conversion Shares.
(l) Good Standing. The Representatives shall have received on and as of the Closing Date or
the Additional Closing Date, as the case may be, satisfactory evidence of the good standing of the
Company and its subsidiaries in their respective jurisdictions of organization and their good
standing as foreign entities in such other jurisdictions as the Representatives may reasonably
request, in each case in writing or any standard form of telecommunication from the appropriate
governmental authorities of such jurisdictions.
(m) Indenture and Securities. The Indenture shall have been duly executed and delivered by
the Company, each of the Guarantors and the Trustee, and the Securities shall have been duly
executed and delivered by the Company and duly authenticated by the Trustee.
(n) DTC. The Securities shall be eligible for clearance and settlement through DTC.
(o) Exchange Listing. The Company shall have used its best efforts to have the Conversion
Shares approved for supplemental listing, subject to official notice of issuance, on the NASDAQ
Global Market.
(p) Lock-up Agreements. The “lock-up” agreements, each substantially in the form of Exhibit A
hereto, from all executive officers and directors of the Company relating to sales and certain
other dispositions of shares of Common Stock or certain other securities,
24
delivered to the
Underwriters on or before the date hereof, shall be full force and effect on the Closing Date or
the Additional Closing Date, as the case may be.
(q) Additional Documents. On or prior to the Closing Date or the Additional Closing Date, as
the case may be, the Company shall have furnished to the Representatives such further certificates
and documents as the Representatives may reasonably request.
All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
7. Indemnification and Contribution.
(a) Indemnification of the Underwriters. The Company and each of the Guarantors jointly and
severally agree to indemnify and hold harmless each Underwriter, its affiliates, directors and
officers and each person, if any, who controls such Underwriter within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims,
damages and liabilities (including, without limitation, legal fees and other reasonable expenses
incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and
expenses are incurred), joint or several, that arise out of, or are based upon, (i) any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement or
caused by any omission or alleged omission to state therein a material fact required to be stated
therein or necessary in order to make the statements therein, not misleading, or (ii) any untrue
statement or alleged untrue statement of a material fact contained in the Prospectus (or any
amendment or supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale
Information (including any Time of Sale Information that has subsequently been amended), or caused
by any omission or alleged omission to state therein a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading, in each case except insofar as such losses, claims, damages or
liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue
statement or omission made in reliance upon and in conformity with any information relating to any
Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use therein, it being understood and agreed that the only such information furnished
by any Underwriter consists of the information described as such in subsection (b) below.
(b) Indemnification of the Company and the Guarantors. Each Underwriter agrees, severally and
not jointly, to indemnify and hold harmless the Company, each of the Guarantors, each of their
respective directors and each of their respective officers who signed the Registration Statement
and each person, if any, who controls the Company or any of the Guarantors within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the
indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or
liabilities that arise out of, or are based upon, any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in
conformity with any information relating to such Underwriter furnished to the Company in
writing by such Underwriter through the Representatives expressly for use in the Registration
Statement, the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing
25
Prospectus or any Time of Sale Information, it being understood and agreed upon that the only such
information furnished by any Underwriter consists of the following information in the Prospectus
furnished on behalf of each Underwriter: the concession and reallowance figures appearing in the
fourth paragraph under the caption “Underwriting” and the information regarding stabilization
transactions contained in the fifteenth and sixteenth paragraphs under the caption “Underwriting.”
(c) Notice and Procedures. If any suit, action, proceeding (including any governmental or
regulatory investigation), claim or demand shall be brought or asserted against any person in
respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above, such
person (the “Indemnified Person”) shall promptly notify the person against whom such
indemnification may be sought (the “Indemnifying Person”) in writing; provided that the
failure to notify the Indemnifying Person shall not relieve it from any liability that it may have
under this Section 7 except to the extent that it has been materially prejudiced (through the
forfeiture of substantive rights or defenses) by such failure; and provided,
further, that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have to an Indemnified Person otherwise than under this Section 7. If any
such proceeding shall be brought or asserted against an Indemnified Person and it shall have
notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified
Person, be counsel to the Indemnifying Person) to represent the Indemnified Person in such
proceeding and shall pay the reasonable fees and expenses of such counsel related to such
proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to
retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such
Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have
mutually agreed to the contrary or (ii) the Indemnifying Person has failed within a reasonable time
to retain counsel reasonably satisfactory to the Indemnified Person. It is understood and agreed
that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in
the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in
addition to any local counsel) for all Indemnified Persons, and that all such reimbursable fees and
expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any
Underwriter, its affiliates, directors and officers and any control persons of such Underwriter
shall be designated in writing by the Representatives and any such separate firm for the Company,
the Guarantors, their respective directors and their respective officers who signed the
Registration Statement and any control persons of the Company and the Guarantors shall be
designated in writing by the Company. The Indemnifying Person shall not be liable for any
settlement of any proceeding effected without its written consent, but if settled with such consent
or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each
Indemnified Person from and against any loss or liability by reason of such settlement or judgment.
Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested
that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as
contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any
proceeding effected without its written consent if (i) such settlement is entered into more than 45
days after receipt by the Indemnifying Person of the proposed terms of the settlement
and (ii) the Indemnifying Person shall not have reimbursed the Indemnified Person in
accordance with such request prior to the date of such settlement. No Indemnifying Person shall,
without the written consent of the Indemnified Person, effect any settlement of any pending or
threatened
26
proceeding in respect of which any Indemnified Person is or would reasonably have been
expected to have been a party and indemnification could have been sought hereunder by such
Indemnified Person, unless such settlement (x) includes an unconditional release of such
Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from
all liability on claims that are the subject matter of such proceeding and (y) does not include any
statement as to or any admission of fault, culpability or a failure to act by or on behalf of any
Indemnified Person.
(d) Contribution. If the indemnification provided for in paragraphs (a) and (b) above is
unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or
liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of
indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by
such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such
proportion as is appropriate to reflect the relative benefits received by the Company and the
Guarantors, on the one hand, and the Underwriters, on the other, from the offering of the
Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in
such proportion as is appropriate to reflect not only the relative benefits referred to in clause
(i) but also the relative fault of the Company and the Guarantors , on the one hand, and the
Underwriters, on the other, in connection with the statements or omissions that resulted in such
losses, claims, damages or liabilities, as well as any other relevant equitable considerations.
The relative benefits received by the Company and the Guarantors, on the one hand, and the
Underwriters, on the other, shall be deemed to be in the same respective proportions as the net
proceeds (before deducting expenses) received by the Company from the sale of the Securities and
the total underwriting discounts and commissions received by the Underwriters in connection
therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the
aggregate offering price of the Securities. The relative fault of the Company and the Guarantors,
on the one hand, and the Underwriters, on the other, shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company or any
Guarantor or by the Underwriters, and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission.
(e) Limitation on Liability. The Company, the Guarantors and the Underwriters agree that it
would not be just and equitable if contribution pursuant to this Section 7 were determined by
pro rata allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified
Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d)
above shall be deemed to include, subject to the limitations set forth above, any legal or other
expenses incurred by such Indemnified Person in connection with any such action or claim.
Notwithstanding the provisions of this Section 7, in no event shall an Underwriter be required to
contribute any amount in excess of the amount by which the total underwriting discounts and
commissions received by such Underwriter with respect to the offering of the
Securities exceeds the amount of any damages that such Underwriter has otherwise been required
to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No
person guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
27
of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. The Underwriters’ obligations to contribute pursuant to this Section
7 are several in proportion to their respective purchase obligations hereunder and not joint.
(f) Non-Exclusive Remedies. The remedies provided for in this Section 7 are not exclusive and
shall not limit any rights or remedies which may otherwise be available to any Indemnified Person
at law or in equity.
28
8. Effectiveness of Agreement. This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto.
9. Termination. This Agreement may be terminated in the absolute discretion of the
Representatives, by notice to the Company, if after the execution and delivery of this Agreement
and prior to the Closing Date or, in the case of the Additional Securities, prior to the Additional
Closing Date (i) trading generally shall have been suspended or materially limited on or by any of
the New York Stock Exchange, the American Stock Exchange, the National Association of Securities
Dealers, Inc., the Chicago Board Options Exchange, the Chicago Mercantile Exchange or the Chicago
Board of Trade; (ii) trading of any securities issued or guaranteed by the Company or any of the
Guarantors shall have been suspended on any exchange or in any over-the-counter market; (iii) a
general moratorium on commercial banking activities shall have been declared by federal or New York
State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities or
any change in financial markets or any calamity or crisis, either within or outside the United
States, that, in the judgment of the Representatives, is material and adverse and makes it
impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on
the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner
contemplated by this Agreement, the Time of Sale Information and the Prospectus.
10. Defaulting Underwriter. If, on the Closing Date or the Additional Closing Date,
as the case may be, any Underwriter defaults on its obligation to purchase the Securities that it
has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their
discretion arrange for the purchase of such Securities by other persons satisfactory to the Company
on the terms contained in this Agreement. If, within 36 hours after any such default by any
Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Securities,
then the Company shall be entitled to a further period of 36 hours within which to procure other
persons satisfactory to the non-defaulting Underwriters to purchase such Securities on such terms.
If other persons become obligated or agree to purchase the Securities of a defaulting Underwriter,
either the non-defaulting Underwriters or the Company may postpone the Closing Date or the
Additional Closing Date, as the case may be, for up to five full business days in order to effect
any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be
necessary in the Registration Statement and the Prospectus or in any other document or arrangement,
and the Company and the Guarantors agree to promptly prepare any amendment or supplement to the
Registration Statement and the Prospectus that effects any such changes. As used in this
Agreement, the term “Underwriter” includes, for all purposes of this Agreement unless the
context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this
Section 10, purchases Securities that a defaulting Underwriter agreed but failed to purchase.
(a) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a) above, the aggregate principal amount of Securities that remain
unpurchased on the Closing Date or the Additional Closing Date, as the case may be, does not exceed
one-eleventh of the aggregate principal amount of Securities to be purchased on such date, then the
Company shall have the right to require each non-defaulting Underwriter to purchase the principal
amount of Securities
29
that such Underwriter agreed to purchase hereunder on such date plus such
Underwriter’s pro rata share (based on the principal amount of Securities that such Underwriter
agreed to purchase on such date) of the Securities of such defaulting Underwriter or Underwriters
for which such arrangements have not been made.
(b) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a) above, the aggregate principal amount of Securities that remain
unpurchased on the Closing Date or the Additional Closing Date, as the case may be, exceeds
one-eleventh of the aggregate amount of Securities to be purchased on such date, or if the Company
shall not exercise the right described in paragraph (b) above, then this Agreement or, with respect
to any Additional Closing Date, the obligation of the Underwriters to purchase Securities on the
Additional Closing Date, as the case may be, shall terminate without liability on the part of the
non-defaulting Underwriters. Any termination of this Agreement pursuant to this Section 10 shall
be without liability on the part of the Company or the Guarantors, except that the Company and each
of the Guarantors will continue to be liable for the payment of expenses as set forth in Section 11
hereof and except that the provisions of Section 7 hereof shall not terminate and shall remain in
effect.
(c) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may
have to the Company, any Guarantor or any non-defaulting Underwriter for damages caused by its
default.
30
11. Payment of Expenses. Whether or not the transactions contemplated by this
Agreement are consummated or this Agreement is terminated, the Company and each of the Guarantors
jointly and severally agree to pay or cause to be paid all costs and expenses incident to the
performance of their respective obligations hereunder, including without limitation, (i) the costs
incident to the authorization, issuance, sale, preparation and delivery of the Securities, the
Guarantees or the Conversion Shares and any taxes payable in that connection; (ii) the costs
incident to the preparation, printing and filing under the Securities Act of the Registration
Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Time of Sale
Information and the Prospectus (including all exhibits, amendments and supplements thereto) and the
distribution thereof; (iii) the costs of reproducing and distributing each of the Transaction
Documents; (iv) the fees and expenses of the Company’s and the Guarantors’ counsel and independent
accountants; (v) the fees and expenses incurred in connection with the registration or
qualification and determination of eligibility for investment of the Securities, the Guarantees or
the Conversion Shares under the laws of such jurisdictions as the Representatives may designate and
the
preparation, printing and distribution of a Blue Sky Memorandum (including the related fees
and expenses of counsel for the Underwriters); (vi) any fees charged by rating agencies for rating
the Securities; (vii) the fees and expenses of the Trustee and any paying agent (including related
fees and expenses of any counsel to such parties); (viii) the cost of preparing stock certificates;
(ix) the costs and charges of any transfer agent and any registrar; (x) all expenses and
application fees incurred in connection with any filing with, and clearance of the offering by, the
National Association of Securities Dealers, Inc.; (xi) all expenses incurred by the Company in
connection with any “road show” presentation to potential investors; (xii) all expenses and
application fees related to the approval of the Securities for book-entry transfer by DTC; and
(xiii) all expenses and application fees related to the listing of the Conversion Shares on the
NASDAQ Global Market.
(a) If (i) this Agreement is terminated pursuant to Section 9, (ii) the Company for any reason
fails to tender the Securities for delivery to the Underwriters or (iii) the Underwriters decline
to purchase the Securities for any reason permitted under this Agreement, the Company and each of
the Guarantors jointly and severally agree to reimburse the Underwriters for all out-of-pocket
costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the
Underwriters in connection with this Agreement and the offering contemplated hereby.
12. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and their respective successors and the officers
and directors and any controlling persons referred to in Section 7 hereof. Nothing in this
Agreement is intended or shall be construed to give any other person any legal or equitable right,
remedy or claim under or in respect of this Agreement or any provision contained herein. No
purchaser of Securities from any Underwriter shall be deemed to be a successor merely by reason of
such purchase.
13. Survival. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company, each of the Guarantors and the Underwriters contained in
this Agreement or made by or on behalf of the Company, each of the Guarantors or the Underwriters
pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery
of and payment for the Securities and shall remain in full force and effect, regardless of
31
any
termination of this Agreement or any investigation made by or on behalf of the Company, the
Guarantors or the Underwriters.
14. Certain Defined Terms. For purposes of this Agreement, (a) except where otherwise
expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities
Act; (b) the term “business day” means any day other than a day on which banks are permitted or
required to be closed in New York City; and (c) the term “subsidiary” has the meaning set forth in
Rule 405 under the Securities Act.
15. Miscellaneous. (a) Authority of the Representatives. Any action by the
Underwriters hereunder may be taken by the Representatives on behalf of the Underwriters, and any
such action taken by the Representatives shall be binding upon the Underwriters.
(b) Notices. All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given if mailed or transmitted and confirmed by
any standard form of telecommunication. Notices to the Underwriters shall be given to the
Representatives c/o X.X. Xxxxxx Securities Inc., 000 Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (fax:
(000) 000-0000), Attention: Equity Syndicate Desk; c/x Xxxxxx Brothers Inc., 000 Xxxxxxx Xxxxxx,
Xxx Xxxx, Xxx Xxxx 00000 (fax: (000) 000-0000), Attention: Syndicate Department; and c/o Deutsche
Bank Securities Inc., 00 Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (fax: (000) 000-0000); Attention:
Syndicate Manager (with a copy to the General Counsel (fax: (000) 000-0000)). Notices to the
Company shall be given to it at 000 00xx Xxxxxx, Xxxxx 0000, Xxxxxx, Xxxxxxxx 00000, (fax: (000)
000-0000); Attention: Executive Vice President, General Counsel and Secretary.
(c) Governing Law. This Agreement shall be governed by and construed in accordance with the
laws of the State of New York.
(d) Counterparts. This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an
original and all of which together shall constitute one and the same instrument.
(e) Amendments or Waivers. No amendment or waiver of any provision of this Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless the same
shall be in writing and signed by the parties hereto.
(f) Headings. The headings herein are included for convenience of reference only and are not
intended to be part of, or to affect the meaning or interpretation of, this Agreement.
32
If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below.
Very truly yours, | ||||||
DELTA PETROLEUM CORPORATION | ||||||
By | /s/ Xxxxxxx X. Xxxxxxxx | |||||
XXXXX PETROLEUM COMPANY | ||||||
By | /s/ Xxxxxxx X. Xxxxxxxx | |||||
DELTA EXPLORATION COMPANY, INC. | ||||||
By | /s/ Xxxxxxx X. Xxxxxxxx | |||||
CASTLE TEXAS EXPLORATION LIMITED PARTNERSHIP | ||||||
By | /s/ Xxxxxxx X. Xxxxxxxx | |||||
DPCA, LLC | ||||||
By | /s/ Xxxxxxx X. Xxxxxxxx | |||||
DLC, INC. | ||||||
By | /s/ Xxxxxxx X. Xxxxxxxx | |||||
33
Accepted: April 19, 2007
For themselves and on behalf of the
several Underwriters listed in
Schedule 1 hereto.
several Underwriters listed in
Schedule 1 hereto.
X.X. XXXXXX SECURITIES INC. | ||||
By |
/s/ Xxxx Xxxxx | |||
XXXXXX BROTHERS INC. | ||||
By |
/s/ Xxxxxx Xxxxxxxxx | |||
DEUTSCHE BANK SECURITIES INC. | ||||
By |
/s/ Xxxxx X.X. Xxxxxx | |||
By |
/s/ Xxx X. Xxxxxxxxx | |||
34
Schedule 1
Underwriter | Principal Amount | |||
X.X. Xxxxxx Securities Inc. |
$ | 37,500,000 | ||
Xxxxxx Brothers Inc. |
27,500,000 | |||
Deutsche Bank Securities Inc. |
15,000,000 | |||
Xxxxxxx Xxxxx & Associates, Inc. |
7,000,000 | |||
Coker, Palmer, Xxxxxxxx & Xxxxxx, Inc. |
5,000,000 | |||
KeyBanc Capital Markets Inc. |
5,000,000 | |||
Tristone Capital (U.S.A.) Inc. |
3,000,000 | |||
Total |
$ | 100,000,000 |
35
Schedule 2
Subsidiary Guarantors
Name | State of Incorporation | |
Piper Petroleum Company
|
Colorado | |
Delta Exploration Company, Inc.
|
Colorado | |
Castle Texas Exploration Limited Partnership
|
Texas | |
DPCA, LLC
|
Delaware | |
DLC, Inc.
|
Colorado |
Annex A
Owned or Controlled Entities
State of | ||||
Subsidiaries | Incorporation | % Ownership | ||
Amber Resources Company of Colorado |
Delaware | 91.68% | ||
Piper Petroleum Company |
Colorado | 100% | ||
Delta Exploration Company, Inc. |
Colorado | 100% | ||
Castle Texas Exploration Limited
Partnership (1) |
Texas | 100% | ||
DPCA, LLC (1) |
Delaware | 100% | ||
DLC, Inc. |
Colorado | 100% | ||
DHS Holding Company |
Delaware | 49.4% | ||
DHS Drilling Company |
Colorado | 49.4% | ||
C&L Drilling Company |
Colorado | 49.4% | ||
Xxxxxxx Trucking Company |
Wyoming | 49.4% | ||
PGR Partners, LLC (1) |
Colorado | 74.37% | ||
CRB Partners, LLC (1) |
Delaware | 56.23% | ||
Polymath Partners, LLC (1) |
Colorado | 70.00% |
(1) | Equity interests are assessable. The Company is the sole general partner or sole managing member of each subsidiary. |
Exhibit A
FORM OF LOCK-UP AGREEMENT
___, 2007
X.X. XXXXXX SECURITIES INC.
XXXXXX BROTHERS INC.
DEUTSCHE BANK SECURITIES INC.
As Representatives of
the several Underwriters listed in
Schedule I to the Underwriting
Agreement referred to below
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
XXXXXX BROTHERS INC.
DEUTSCHE BANK SECURITIES INC.
As Representatives of
the several Underwriters listed in
Schedule I to the Underwriting
Agreement referred to below
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
Re: Delta Petroleum Corporation – Public Offering
Ladies and Gentlemen:
The undersigned understands that you, as Representatives of the several Underwriters, propose
to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Delta Petroleum
Corporation, a Delaware corporation (the “Company”) and the subsidiaries of the Company listed in
Annex A to the Underwriting Agreement, providing for the public offering (the “Public Offering”) by
the several Underwriters named in Schedule I to the Underwriting Agreement (the “Underwriters”), of
the Company’s Convertible Senior Notes due 2037 (the “Securities”). Capitalized terms used herein
and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
In consideration of the Underwriters’ agreement to purchase and make the Public Offering of
the Securities, and for other good and valuable consideration receipt of which is hereby
acknowledged, the undersigned hereby agrees that, without the prior written consent of X.X. Xxxxxx
Securities Inc., the undersigned will not, during the period ending 90 days after the date of the
final prospectus relating to the Public Offering (the “Prospectus”), (1) offer, pledge, announce
the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase
any option or contract to sell, grant any option, right or warrant to purchase, or otherwise
transfer or dispose of, directly or indirectly, any shares of Common Stock, $0.01 per share par
value, of the Company (the “Common Stock”) or any securities convertible into or exercisable or
exchangeable for Common Stock (including without limitation, Common Stock which may be deemed to be
beneficially owned by the undersigned in accordance with the rules and regulations of the
Securities and Exchange Commission (the “SEC”) and securities which may be issued upon exercise of
a stock option or warrant) or (2) enter into any swap or other agreement that transfers, in whole
or in part, any of the economic consequences of ownership of the Common Stock, whether any such
transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or
such other securities, in cash or otherwise. In addition, the undersigned agrees that, without the
prior written consent of X.X. Xxxxxx Securities Inc., it
2
will not, during the period ending 90 days after the date of the Prospectus, make any demand
for or exercise any right with respect to, the registration of any shares of Common Stock or any
security convertible into or exercisable or exchangeable for Common Stock. Notwithstanding the
foregoing, if (1) during the last 17 days of the 90-day restricted period, the Company issues an
earnings release or material news or a material event relating to the Company occurs; or (2) prior
to the expiration of the 90-day restricted period, the Company announces that it will release
earnings results during the 16-day period beginning on the last day of the 90-day period, the
restrictions imposed by this Letter Agreement shall continue to apply until the expiration of the
18-day period beginning on the issuance of the earnings release or the occurrence of the material
news or material event (such 90-day restricted period, so extended, the “Lock-Up Period”).
The restrictions described in the immediately preceding paragraph shall not apply to:
(i) | transfers by the undersigned of Common Stock as a bona fide gift or transfer by will or the laws of intestate succession, so long as (1) each transferee agrees in writing to be subject to the restrictions set forth herein, (2) the Underwriters have been advised in writing at least two business days prior to the proposed transfer and (3) no filing by any party with the SEC or any other public disclosure shall be required or voluntarily made in connection with such transfer during the Lock-Up Period; or | ||
(ii) | transfers by the undersigned of Common Stock to any trust, partnership or limited liability company for the direct or indirect benefit of such person for estate planning purposes, so long as (1) the trustee, partnership or limited liability company agrees in writing to be subject to the restrictions set forth herein, (2) any such transfer shall not involve a disposition for value and (3) no filing by any party with the SEC or any other public disclosure shall be required or voluntarily made in connection with such transfer during the Lock-Up Period. |
In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the
registration or transfer of the securities described herein, are hereby authorized to decline to
make any transfer of securities if such transfer would constitute a violation or breach of this
Letter Agreement.
The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this Letter Agreement. All authority herein conferred or agreed to be
conferred and any obligations of the undersigned shall be binding upon the successors, assigns,
heirs or personal representatives of the undersigned.
The undersigned understands that, if the Underwriting Agreement does not become effective, or
if the Underwriting Agreement (other than the provisions thereof which survive termination) shall
terminate or be terminated prior to payment for and delivery of the Common Stock to be sold
thereunder, the undersigned shall be released from all obligations under this Letter Agreement.
The undersigned understands that the Underwriters are entering into the Underwriting Agreement and
proceeding with the Public Offering in reliance upon this Letter Agreement.
3
This Letter Agreement shall be governed by and construed in accordance with the laws of the
State of New York, without regard to the conflict of laws principles thereof.
Very truly yours, | ||||